Pharmaceutical Excipients Market by Type (Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides), Organic Chemicals (Carbohydrates, Petrochemicals)) and Function (Fillers and diluents, Binders, Coatings, Flavoring agents, Disintegrants, Colorants) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020
Pharmaceuticals excipient is a substance added with an active ingredient during manufacturing process of a drug. It helps in long term stabilization, reduction of viscosity, and enhancement of solubility of a drug. The prevention of denaturation of active ingredient at the time of manufacturing process of drug is possible through excipients. It also enhances of taste & appearance of medicines. Pharmaceutical excipients help in transportation of drug to intended part of body and disintegration of drug into small particles to reach blood stream faster.
The growth of the global pharmaceuticals market and emergence of new excipients are factors that fuel the growth of the world pharmaceuticals excipients market. However, declining R&D investments and increased regulatory requirements leading to shortage of FDA-approved manufacturing sites. An advancement in nanotechnology and multi-functionality excipients are creating opportunities in the market.The world pharmaceutical excipients market is segmented based on products, functionality, routes of administration, and geography. The products covered in the report include organic and inorganic chemicals. On the basis of functionality, the market is classified into fillers, binders, lubricants, and preservatives. Oral, topical, parenteral, and others are routes of administration discussed in the report. The market is divided geographically into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
Some of the prominent players in this market are BASF SE, Ashland Inc., The Dow Chemical Company, Evonik Industries, Roquette, Colorcon Inc., FMC Corporation, Avantor Performance Materials Inc., and Lubrizol Corporation. Various strategies such as collaborations, expansions, joint ventures, acquisitions, and new product launches have helped these companies to strengthen their position in this competitive market.
KEY BENEFITS FOR STAKEHOLDERS:
The growth of the global pharmaceuticals market and emergence of new excipients are factors that fuel the growth of the world pharmaceuticals excipients market. However, declining R&D investments and increased regulatory requirements leading to shortage of FDA-approved manufacturing sites. An advancement in nanotechnology and multi-functionality excipients are creating opportunities in the market.The world pharmaceutical excipients market is segmented based on products, functionality, routes of administration, and geography. The products covered in the report include organic and inorganic chemicals. On the basis of functionality, the market is classified into fillers, binders, lubricants, and preservatives. Oral, topical, parenteral, and others are routes of administration discussed in the report. The market is divided geographically into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
Some of the prominent players in this market are BASF SE, Ashland Inc., The Dow Chemical Company, Evonik Industries, Roquette, Colorcon Inc., FMC Corporation, Avantor Performance Materials Inc., and Lubrizol Corporation. Various strategies such as collaborations, expansions, joint ventures, acquisitions, and new product launches have helped these companies to strengthen their position in this competitive market.
KEY BENEFITS FOR STAKEHOLDERS:
- The report offers a detailed analysis of key driving and restraining factors of the world pharmaceutical excipients market.
- This report offers an in-depth quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
- An exhaustive analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
- The report provides an extensive analysis of current and future market status of the world pharmaceutical excipients market.
- Comprehensive analysis has been done in this report by constructing market estimations for the key market segments between 2015 and 2020.
- An extensive analysis of current research and clinical developments withinthe world pharmaceutical excipients market is provided with key market dynamic factors that help in understanding the behavior of the market.
- The world pharmaceutical excipients market is segmented into North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).
- By Product
- Organic Chemicals
- Inorganic Chemicals
- By Functionality
- Fillers
- Binders
- Lubricants
- Preservatives
- By Routes of Administration
- Oral
- Topical
- Parenteral
- Others
- By Geography
- North America
- Asia-Pacific
- Europe
- Latin America, Middle East and Africa (LAMEA)
- BASF SE
- Ashland Inc.
- The Dow Chemical Company
- Evonik Industries
- Roquette
- Colorcon Inc.
- FMC Corporation
- Avantor Performance Materials Inc.
- Lubrizol Corporation
CHAPTER: 1 INTRODUCTION
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2020
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective
3.4 Nanotechnology in excipient
3.5 Emerging role of excipients in the pharmaceutical industry
3.6 Porters five force analysis
3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players
3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials
3.9.1 A study of insulin lispro with biochaperone excipients in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study
3.10 Market dynamics
3.10.1 Drivers
3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings
3.10.2 Restraints
3.10.2.1 Supply chain issues
3.10.2.2 SegregatedPHARMACEUTICAL EXCIPIENTS market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment
3.10.3 Opportunities
3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development
CHAPTER 4 PHARMACEUTICAL EXCIPIENTS MARKET BY TYPE, 2014-2020
4.1 Overview
4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.2 Inorganic Chemicals
4.2.1 Market size and forecast
4.2.2 Calcium Phosphates
4.2.2.1 Market size and forecast
4.2.3 Calcium Carbonate
4.2.3.1 Market size and forecast
4.2.4 Calcium Sulfate
4.2.4.1 Market size and forecast
4.2.5 Halites
4.2.5.1 Market size and forecast
4.2.6 Metallic Oxides
4.2.6.1 Market size and forecast
4.2.7 Others
4.2.7.1 Market size and forecast
4.3 Organic chemicals
4.3.1 Market size and forecast
4.3.2 Carbohydrates
4.3.2.1 Market size and foreast
4.3.2.2 Sugars
4.3.2.2.1 MARKET SIZE AND FORECAST
4.3.2.3 Starch
4.3.2.3.1 MARKET SIZE AND FORECAST
4.3.2.4 Cellulose
4.3.2.4.1 MARKET SIZE AND FORECAST
4.3.3 Petrochemicals
4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)
4.3.3.2.1 MARKET SIZE AND FORECAST
4.3.3.3 Povidones Polymers
4.3.3.3.1 MARKET SIZE AND FORECAST
4.3.3.4 Mineral Hydrocarbons
4.3.3.4.1 MARKET SIZE AND FORECAST
4.3.3.5 Oleochemicals
4.3.3.5.1 MARKET SIZE AND FORECAST
4.3.3.6 Gelatin (Proteins)
4.3.3.6.1 MARKET SIZE AND FORECAST
CHAPTER 5 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2014-2020
5.1 Overview
5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast
5.2 Fillers & Diluents
5.2.1 Market size and forecast
5.3 Suspension & viscosity agents
5.3.1 Market size and forecast
5.4 Binders
5.4.1 Market size and forecast
5.5 Coatings
5.5.1 Market size and forecast
5.6 Flavoring agents
5.6.1 Market size and forecast
5.7 Disintegrants
5.7.1 Market size and forecast
5.8 Colorants
5.8.1 Market size and forecast
5.9 Others
5.9.1 Lubricants & Glidants
5.9.1.1 Role of lubricants
5.9.2 Preservatives
5.9.3 Market size and forecast
CHAPTER 6 PHARMACEUTICAL EXCIPIENTS MARKET BY GEOGRAPHY, 2014-2020
6.1 Overview
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Ashland Inc.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.
7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement
7.1.5 SWOT analysis of Ashland Inc.
7.2 Associated British Food Plc
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc
7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance
7.2.5 SWOT analysis of Associated British Food Plc
7.3 AkzoNobel
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel
7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition
7.3.4 SWOT analysis of AkzoNobel
7.4 Evonik
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik
7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion
7.4.5 SWOT analysis of Evonik
7.5 J.M. Huber Corporation
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation
7.5.3.1 Primary Strategies: expansion
7.5.4 SWOT analysis of J.M. Huber Corporation
7.6 Archer Daniels Midland
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland
7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations
7.6.4 SWOT analysis of Archer Daniels Midland
7.7 BASF
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF
7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition
7.7.4 SWOT analysis of BASF
7.8 Dow Chemical Corporation
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation
7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches
7.8.5 SWOT analysis of Dow Chemical Corporation
7.9 Merck Millipore
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore
7.9.4.1 Primary Strategies: Product Launch
7.9.5 SWOT analysis of Merck Millipore
7.10 Croda International plc
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.
7.10.4.1 Primary Strategies: approval and expansion
7.10.5 SWOT analysis of Croda International plc.
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2020
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective
3.4 Nanotechnology in excipient
3.5 Emerging role of excipients in the pharmaceutical industry
3.6 Porters five force analysis
3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players
3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials
3.9.1 A study of insulin lispro with biochaperone excipients in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study
3.10 Market dynamics
3.10.1 Drivers
3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings
3.10.2 Restraints
3.10.2.1 Supply chain issues
3.10.2.2 SegregatedPHARMACEUTICAL EXCIPIENTS market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment
3.10.3 Opportunities
3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development
CHAPTER 4 PHARMACEUTICAL EXCIPIENTS MARKET BY TYPE, 2014-2020
4.1 Overview
4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast
4.2 Inorganic Chemicals
4.2.1 Market size and forecast
4.2.2 Calcium Phosphates
4.2.2.1 Market size and forecast
4.2.3 Calcium Carbonate
4.2.3.1 Market size and forecast
4.2.4 Calcium Sulfate
4.2.4.1 Market size and forecast
4.2.5 Halites
4.2.5.1 Market size and forecast
4.2.6 Metallic Oxides
4.2.6.1 Market size and forecast
4.2.7 Others
4.2.7.1 Market size and forecast
4.3 Organic chemicals
4.3.1 Market size and forecast
4.3.2 Carbohydrates
4.3.2.1 Market size and foreast
4.3.2.2 Sugars
4.3.2.2.1 MARKET SIZE AND FORECAST
4.3.2.3 Starch
4.3.2.3.1 MARKET SIZE AND FORECAST
4.3.2.4 Cellulose
4.3.2.4.1 MARKET SIZE AND FORECAST
4.3.3 Petrochemicals
4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)
4.3.3.2.1 MARKET SIZE AND FORECAST
4.3.3.3 Povidones Polymers
4.3.3.3.1 MARKET SIZE AND FORECAST
4.3.3.4 Mineral Hydrocarbons
4.3.3.4.1 MARKET SIZE AND FORECAST
4.3.3.5 Oleochemicals
4.3.3.5.1 MARKET SIZE AND FORECAST
4.3.3.6 Gelatin (Proteins)
4.3.3.6.1 MARKET SIZE AND FORECAST
CHAPTER 5 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2014-2020
5.1 Overview
5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast
5.2 Fillers & Diluents
5.2.1 Market size and forecast
5.3 Suspension & viscosity agents
5.3.1 Market size and forecast
5.4 Binders
5.4.1 Market size and forecast
5.5 Coatings
5.5.1 Market size and forecast
5.6 Flavoring agents
5.6.1 Market size and forecast
5.7 Disintegrants
5.7.1 Market size and forecast
5.8 Colorants
5.8.1 Market size and forecast
5.9 Others
5.9.1 Lubricants & Glidants
5.9.1.1 Role of lubricants
5.9.2 Preservatives
5.9.3 Market size and forecast
CHAPTER 6 PHARMACEUTICAL EXCIPIENTS MARKET BY GEOGRAPHY, 2014-2020
6.1 Overview
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Ashland Inc.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.
7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement
7.1.5 SWOT analysis of Ashland Inc.
7.2 Associated British Food Plc
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc
7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance
7.2.5 SWOT analysis of Associated British Food Plc
7.3 AkzoNobel
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel
7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition
7.3.4 SWOT analysis of AkzoNobel
7.4 Evonik
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik
7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion
7.4.5 SWOT analysis of Evonik
7.5 J.M. Huber Corporation
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation
7.5.3.1 Primary Strategies: expansion
7.5.4 SWOT analysis of J.M. Huber Corporation
7.6 Archer Daniels Midland
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland
7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations
7.6.4 SWOT analysis of Archer Daniels Midland
7.7 BASF
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF
7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition
7.7.4 SWOT analysis of BASF
7.8 Dow Chemical Corporation
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation
7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches
7.8.5 SWOT analysis of Dow Chemical Corporation
7.9 Merck Millipore
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore
7.9.4.1 Primary Strategies: Product Launch
7.9.5 SWOT analysis of Merck Millipore
7.10 Croda International plc
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.
7.10.4.1 Primary Strategies: approval and expansion
7.10.5 SWOT analysis of Croda International plc.
LIST OF TABLES
TABLE 1 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 2 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 4 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 5 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 6 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 7 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY TYPE, 2014-2020 (TONNES)
TABLE 8 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)
TABLE 9 WORLD INORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 10 WORLD CALCIUM PHOSPHATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 WORLD CALCIUM CARBONATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 12 WORLD CALCIUM SULFATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 13 WORLD HALITES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 WORLD METALLIC OXIDES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 WORLD OTHERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 WORLD ORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 17 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 18 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 20 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 21 WORLD CELLULOSE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 22 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 23 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 24 WORLD GLYCOLS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 25 FEATURES AND BENEFITS OF POVIDONES POLYMERS
TABLE 26 WORLD POVIDONE POLYMERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 27 WORLD MINERAL HYDROCARBONS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 28 WORLD OLEOCHEMICALS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 29 WORLD GELATIN EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 30 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY FUNCTION, 2014-2020, (TONNES)
TABLE 31 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 32 WORLD FILLERS& DILUENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 33 WORLD SUSPENSION & VISCOSITY AGENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 TYPES OF BINDERS USED AS EXCIPIENTS
TABLE 35 COMMON TYPE OF BINDERS USED IN THE MARKET
TABLE 36 WORLD BINDERS EXCIPIENTMARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 WORLD COATINGS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 38 WORLD FLAVORING AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 49 WORLD DISINTEGRANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 WORLD COLORANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 41 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, (TONNES)
TABLE 43 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONS, 2014-2020, ($MILLION)
TABLE 45 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 46 ASIA PACIFIC EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 47 LAMEA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 48 ASHLAND INC. COMPANY SNAPSHOT
TABLE 59 ASSOCIATED BRITISH FOOD PLC COMPANY SNAPSHOT
TABLE 50 AKZONOBEL COMPANY SNAPSHOT
TABLE 51 EVONIK COMPANY SNAPSHOT
TABLE 52 J.M. HUBER CORPORATION COMPANY SNAPSHOT
TABLE 53 ARCHER DANIELS MIDLAND COMPANY SNAPSHOT
TABLE 54 BASF COMPANY SNAPSHOT
TABLE 55 DOW CHEMICAL CORPORATION COMPANY SNAPSHOT
TABLE 56 SNAPSHOT OF MERCK MILLIPORE
TABLE 57 SNAPSHOT OF CRODA
TABLE 1 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 2 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 4 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 5 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 6 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 7 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY TYPE, 2014-2020 (TONNES)
TABLE 8 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)
TABLE 9 WORLD INORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 10 WORLD CALCIUM PHOSPHATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 WORLD CALCIUM CARBONATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 12 WORLD CALCIUM SULFATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 13 WORLD HALITES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 WORLD METALLIC OXIDES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 WORLD OTHERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 WORLD ORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 17 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 18 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 20 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 21 WORLD CELLULOSE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 22 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 23 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 24 WORLD GLYCOLS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 25 FEATURES AND BENEFITS OF POVIDONES POLYMERS
TABLE 26 WORLD POVIDONE POLYMERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 27 WORLD MINERAL HYDROCARBONS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 28 WORLD OLEOCHEMICALS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 29 WORLD GELATIN EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 30 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY FUNCTION, 2014-2020, (TONNES)
TABLE 31 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 32 WORLD FILLERS& DILUENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 33 WORLD SUSPENSION & VISCOSITY AGENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 TYPES OF BINDERS USED AS EXCIPIENTS
TABLE 35 COMMON TYPE OF BINDERS USED IN THE MARKET
TABLE 36 WORLD BINDERS EXCIPIENTMARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 WORLD COATINGS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 38 WORLD FLAVORING AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 49 WORLD DISINTEGRANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 WORLD COLORANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 41 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, (TONNES)
TABLE 43 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONS, 2014-2020, ($MILLION)
TABLE 45 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 46 ASIA PACIFIC EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 47 LAMEA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 48 ASHLAND INC. COMPANY SNAPSHOT
TABLE 59 ASSOCIATED BRITISH FOOD PLC COMPANY SNAPSHOT
TABLE 50 AKZONOBEL COMPANY SNAPSHOT
TABLE 51 EVONIK COMPANY SNAPSHOT
TABLE 52 J.M. HUBER CORPORATION COMPANY SNAPSHOT
TABLE 53 ARCHER DANIELS MIDLAND COMPANY SNAPSHOT
TABLE 54 BASF COMPANY SNAPSHOT
TABLE 55 DOW CHEMICAL CORPORATION COMPANY SNAPSHOT
TABLE 56 SNAPSHOT OF MERCK MILLIPORE
TABLE 57 SNAPSHOT OF CRODA
LIST OF FIGURES
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 WORLD PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION
FIG. 5 TOP INVESTMENT POCKETS IN THE WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014
FIG. 6 DISTRIBUTION OF TOP WINNING STRATEGIES
FIG. 7 PORTERS FIVE FORCE ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 8 VALUE CHAIN ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 9 PATENT ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET FROM 2014-2015
FIG. 10 TOP FACTORS IMPACTING WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014-2020
FIG. 11 KEY FINANCIALS OF ASHLAND INC. BY GEOGRAPHY (2014)
FIG. 12 KEY FINANCIALS OF ASHLAND INC. BY REPORTABLE SEGMENTS (2014)
FIG. 13 SWOT ANALYSIS OF ASHLAND INC.
FIG. 14 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY GEOGRAPHY (2015)
FIG. 15 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY REPORTABLE SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF ASSOCIATED BRITISH FOOD PLC
FIG. 17 KEY FINANCIALS OF AKZONOBEL BY GEOGRAPHY (2014)
FIG. 18 KEY FINANCIALS OF AKZONOBEL BY SEGMENTS (2014)
FIG. 19 SWOT ANALYSIS OF AKZONOBEL
FIG. 20 KEY FINANCIALS OF EVONIK BY BUSINESSES (2014)
FIG. 21 KEY FINANCIALS OF EVONIK BY SEGMENTS (2014)
FIG. 22 SWOT ANALYSIS OF EVONIK
FIG. 23 SWOT ANALYSIS OF J.M. HUBER CORPORATION
FIG. 24 KEY FINANCIALS OF ARCHER DANIELS MIDLAND BY BUSINESSES (2014)
FIG. 25 SWOT ANALYSIS OF ARCHER DANIELS MIDLAND
FIG. 26 KEY FINANCIALS OF BASF BY GEOGRAPHY (2014)
FIG. 27 KEY FINANCIAL OF BASF BY SALES BY REPORTABLE SEGMENTS (2014)
FIG. 28 SWOT ANALYSIS OF BASF
FIG. 29 KEY FINANCIALS OF DOW CHEMICAL CORPORATION BY GEOGRAPHY (2014)
FIG. 30 KEY FINANCIAL OF DOW CHEMICAL CORPORATION BY REPORTABLE SEGMENTS (2014)
FIG. 31 SWOT ANALYSIS OF DOW CHEMICAL CORPORATION
FIG. 32 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHY (2014)
FIG. 33 FINANCIAL REVENUES OF MERCK MILLIPORE BY BUSINESS SEGMENT (2014)
FIG. 34 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 35 FINANCIAL REVENUES OF CRODA BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES OF CRODA BY BUSINESS SEGMENT (2014)
FIG. 37 SWOT ANALYSIS OF CRODA
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 WORLD PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION
FIG. 5 TOP INVESTMENT POCKETS IN THE WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014
FIG. 6 DISTRIBUTION OF TOP WINNING STRATEGIES
FIG. 7 PORTERS FIVE FORCE ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 8 VALUE CHAIN ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 9 PATENT ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET FROM 2014-2015
FIG. 10 TOP FACTORS IMPACTING WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014-2020
FIG. 11 KEY FINANCIALS OF ASHLAND INC. BY GEOGRAPHY (2014)
FIG. 12 KEY FINANCIALS OF ASHLAND INC. BY REPORTABLE SEGMENTS (2014)
FIG. 13 SWOT ANALYSIS OF ASHLAND INC.
FIG. 14 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY GEOGRAPHY (2015)
FIG. 15 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY REPORTABLE SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF ASSOCIATED BRITISH FOOD PLC
FIG. 17 KEY FINANCIALS OF AKZONOBEL BY GEOGRAPHY (2014)
FIG. 18 KEY FINANCIALS OF AKZONOBEL BY SEGMENTS (2014)
FIG. 19 SWOT ANALYSIS OF AKZONOBEL
FIG. 20 KEY FINANCIALS OF EVONIK BY BUSINESSES (2014)
FIG. 21 KEY FINANCIALS OF EVONIK BY SEGMENTS (2014)
FIG. 22 SWOT ANALYSIS OF EVONIK
FIG. 23 SWOT ANALYSIS OF J.M. HUBER CORPORATION
FIG. 24 KEY FINANCIALS OF ARCHER DANIELS MIDLAND BY BUSINESSES (2014)
FIG. 25 SWOT ANALYSIS OF ARCHER DANIELS MIDLAND
FIG. 26 KEY FINANCIALS OF BASF BY GEOGRAPHY (2014)
FIG. 27 KEY FINANCIAL OF BASF BY SALES BY REPORTABLE SEGMENTS (2014)
FIG. 28 SWOT ANALYSIS OF BASF
FIG. 29 KEY FINANCIALS OF DOW CHEMICAL CORPORATION BY GEOGRAPHY (2014)
FIG. 30 KEY FINANCIAL OF DOW CHEMICAL CORPORATION BY REPORTABLE SEGMENTS (2014)
FIG. 31 SWOT ANALYSIS OF DOW CHEMICAL CORPORATION
FIG. 32 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHY (2014)
FIG. 33 FINANCIAL REVENUES OF MERCK MILLIPORE BY BUSINESS SEGMENT (2014)
FIG. 34 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 35 FINANCIAL REVENUES OF CRODA BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES OF CRODA BY BUSINESS SEGMENT (2014)
FIG. 37 SWOT ANALYSIS OF CRODA
